Luther King Capital Management Corporation and J. Luther King, Jr. Report 4.0% Ownership in scPharmaceuticals Inc.

Luther King Capital Management Corporation and J. Luther King, Jr. have filed a Schedule 13G/A amendment reporting a 4.0% ownership in scPharmaceuticals Inc. The filing indicates that both entities beneficially own 2,128,391 shares of common stock, with sole voting and dispositive power over these shares. The filing is made under Rule 13d-1(b) and Rule 13d-1(c), and it certifies that the shares were acquired and are held in the ordinary course of business, not for the purpose of influencing the control of the issuer. The filing is signed by J. Luther King, Jr., who is the President of Luther King Capital Management Corporation.